Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Tilleke & GibbinsWaralee Sripawadkul of Tilleke & Gibbins says that the overturning of a decision on a trademark application by ExxonMobil could have a substantial impact in the area of non-traditional marks -
Sponsored by Tilleke & GibbinsLinh Thi Mai Nguyen and Chi Lan Dang of Tilleke & Gibbins summarise the main changes proposed under a draft decree on copyright and related rights in Vietnam
-
Sponsored by LexOrbisManisha Singh and Ritika Agarwal of LexOrbis analyse several recent rulings by the High Court of Delhi in appeals against decisions by the Registrar of Trademarks
-
Sponsored by Wanhuida Intellectual PropertyTiejun Tang, Yuming Wang, and Jianhui Li of Wanhuida Intellectual Property discuss the evolving landscape in China around ‘offering for sale’, with reference to a high-profile Supreme People’s Court case involving a patented drug
-
Sponsored by Maiwald Intellectual PropertyMarco Stief of Maiwald explains a ruling by the Düsseldorf Regional Court in the matter NuCana v Gilead that establishes the subsidiarity of the objection of disproportionality with regard to a compulsory licensing action
-
Sponsored by Patrinos & KilimirisConstantinos Kilimiris of Patrinos & Kilimiris explains why a ruling by the Athens First Instance Single Member Court is an important addition to the body of case law on the doctrine of equivalents
